Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection After Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis
The Journal of Arthroplasty · 2026-05
DOI: 10.1016/j.arth.2026.05.035 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Arthroplasty, 2026-05. Verfasst von Andrzej Bałoniak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Orthopaedics, Musculoskeletal Oncology and Trauma Surgery, Poznan University of Medical Sciences, Poznan, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This study aimed to evaluate the effectiveness of debridement, antibiotics, and implant retention (DAIR) in treating periprosthetic joint infection (PJI) after unicompartmental knee arthroplasty (UKA). METHODS: A systematic search of PubMed, Embase, and Cochrane Library was performed to identify studies reporting outcomes of DAIR for PJI after UKA. A single-arm meta-analysis using a random-effects model was conducted to estimate the pooled infection-free survival and all-cause implant survival. Additionally, pooled Kaplan-Meier survival estimates were calculated when time-to-event data were available. The risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Tool. Subgroup analyses based on the duration of follow-up were performed, and publication bias was evaluated using funnel plots. Outlier studies were identified using sensitivity analysis. RESULTS: Overall, nine studies including 165 patients who had medial and lateral UKA were included in the analysis. Across studies with follow-up ranging from one year to more than 10 years, infection-free survival following DAIR was 72% (95% confidence interval [CI], 60 to 82), and all-cause implant survival was 67% (95% CI, 34 to 89) in the pooled proportion analysis. In the pooled Kaplan-Meier survival analysis, the infection-free survival rate was 62% (95% CI, 38 to 82). The incidence of conversion to TKA was 34% (95% CI, 17 to 57), and repeat DAIR was 17% (95% CI, 11 to 25). The pooled incidence of Staphylococcus aureus was 39% among cases treated with DAIR (95% CI, 30 to 49). CONCLUSIONS: A DAIR for treating PJI following UKA demonstrated moderate infection control rates. Given the limited availability of comparative UKA-specific data, further studies directly comparing DAIR with one- and two-stage revision strategies are needed to better define the optimal treatment pathways for this patient population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Orthopaedics, Musculoskeletal Oncology and Trauma Surgery, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Orthopedics and Traumatology, Graz, Austria.
- Instituto de Ortopedia e Traumatologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Zitieren
APA
Bałoniak, A., Jancevski, T., & Martins, E. C. (2026). Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection After Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.05.035
Vancouver
Bałoniak A, Jancevski T, Martins EC. Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection After Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.05.035
BibTeX
@article{Baoniak2026,
author = {Bałoniak, Andrzej and Jancevski, Tin and Martins, Eduardo C},
title = {Debridement, Antibiotics, and Implant Retention in Periprosthetic Joint Infection After Unicompartmental Knee Arthroplasty: A Systematic Review and Meta-Analysis},
journal = {The Journal of Arthroplasty},
year = {2026},
doi = {10.1016/j.arth.2026.05.035}
}
EUVIMED